Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
39.38
+1.27 (3.33%)
At close: Dec 5, 2025, 4:00 PM EST
39.98
+0.60 (1.52%)
After-hours: Dec 5, 2025, 6:51 PM EST

Zenas BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,114342--
Enterprise Value
1,824-44--
Last Close Price
39.388.19--
PS Ratio
110.1168.45--
PB Ratio
8.461.10--
P/TBV Ratio
10.761.10--
Debt / Equity Ratio
0.000.000.870.03
Asset Turnover
0.040.020.70-
Quick Ratio
5.576.122.442.59
Current Ratio
5.666.212.572.64
Return on Equity (ROE)
-68.33%-93.22%-102.89%-
Return on Assets (ROA)
-33.72%-46.76%-23.77%-
Return on Capital (ROIC)
-43.91%-57.07%-35.79%-
Return on Capital Employed (ROCE)
-72.60%-52.40%-60.40%-154.70%
Earnings Yield
-8.98%-45.87%--
FCF Yield
-7.50%-35.00%--
Buyback Yield / Dilution
-1252.33%-762.01%-2.61%-
Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q